Skip to contentL
Lifecore Biomedical, Inc.
L
LFCRLifecore Biomedical, Inc. Q3 2017 · 10-Q
Revenue$129.29M$129.29M−0.5% vs Q3 2016 Net Income$3.50M$3.50MN/M vs Q3 2016 EPS Diluted$0.13$0.13N/M vs Q3 2016 Gross Profit$22,873,000+76.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lifecore Biomedical, Inc. · CIK 1005286 · Engraved from SEC EDGAR
Operating Cash Flow$26,626,000+541.9% Free Cash Flowderived$12,904,000N/M Margins · derivedGross margin17.7%+7.7 pt vs Q3 2016
Operating margin3.3%+29.2 pt vs Q3 2016
Net margin2.7%+19.0 pt vs Q3 2016
ended Feb 26, 2017 · filed Apr 7, 2017 · 40 d after period end